Low-density lipoproteins and risk for coronary artery disease
- 1 November 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (8) , 3-12
- https://doi.org/10.1016/s0002-9149(98)00769-3
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia∗∗See Appendix for list of principal investigators, study sites, and laboratory sites.The American Journal of Cardiology, 1998
- Task force 8. Organization of preventive cardiology serviceJournal of the American College of Cardiology, 1996
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- Lipid-lowering interventions in angiographic trialsThe American Journal of Cardiology, 1995
- Range of serum cholesterol values in the population developing coronary artery diseaseThe American Journal of Cardiology, 1995
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Fluvastatin with and without niacin for hypercholesterolemiaThe American Journal of Cardiology, 1994
- Combination therapy with fluvastatin and niacin in hypercholesterolemia: A preliminary report on safetyThe American Journal of Cardiology, 1994
- Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterolJournal of the American College of Cardiology, 1994
- Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemiasThe American Journal of Cardiology, 1992